140 related articles for article (PubMed ID: 12642173)
21. Analyses of [(18)F] altanserin bolus injection PET data. I: consideration of radiolabeled metabolites in baboons.
Price JC; Lopresti BJ; Mason NS; Holt DP; Huang Y; Mathis CA
Synapse; 2001 Jul; 41(1):1-10. PubMed ID: 11354008
[TBL] [Abstract][Full Text] [Related]
22. Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin.
Ettrup A; Svarer C; McMahon B; da Cunha-Bang S; Lehel S; Møller K; Dyssegaard A; Ganz M; Beliveau V; Jørgensen LM; Gillings N; Knudsen GM
Neuroimage; 2016 Apr; 130():167-174. PubMed ID: 26876490
[TBL] [Abstract][Full Text] [Related]
23. Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex.
Biver F; Wikler D; Lotstra F; Damhaut P; Goldman S; Mendlewicz J
Br J Psychiatry; 1997 Nov; 171():444-8. PubMed ID: 9463603
[TBL] [Abstract][Full Text] [Related]
24. Clomipramine augmentation in treatment-resistant depression.
Amsterdam JD; García-España F; Rosenzweig M
Depress Anxiety; 1997; 5(2):84-90. PubMed ID: 9262938
[TBL] [Abstract][Full Text] [Related]
25. Modulating the serotonin system in the treatment of major depressive disorder.
Morrissette DA; Stahl SM
CNS Spectr; 2014 Dec; 19 Suppl 1():57-67; quiz 54-7, 68. PubMed ID: 25544378
[TBL] [Abstract][Full Text] [Related]
26. Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography.
Mintun MA; Sheline YI; Moerlein SM; Vlassenko AG; Huang Y; Snyder AZ
Biol Psychiatry; 2004 Feb; 55(3):217-24. PubMed ID: 14744461
[TBL] [Abstract][Full Text] [Related]
27. Central serotonergic S2 binding in Papio anubis measured in vivo with N-omega-[18F]fluoroethylketanserin and PET.
Moerlein SM; Perlmutter JS
Neurosci Lett; 1991 Feb; 123(1):23-6. PubMed ID: 2062450
[TBL] [Abstract][Full Text] [Related]
28. Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET and the bolus/infusion approach.
Pinborg LH; Adams KH; Svarer C; Holm S; Hasselbalch SG; Haugbøl S; Madsen J; Knudsen GM
J Cereb Blood Flow Metab; 2003 Aug; 23(8):985-96. PubMed ID: 12902843
[TBL] [Abstract][Full Text] [Related]
29. PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders.
Meltzer CC; Price JC; Mathis CA; Greer PJ; Cantwell MN; Houck PR; Mulsant BH; Ben-Eliezer D; Lopresti B; DeKosky ST; Reynolds CF
Am J Psychiatry; 1999 Dec; 156(12):1871-8. PubMed ID: 10588399
[TBL] [Abstract][Full Text] [Related]
30. Reduced binding of [18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction.
Meltzer CC; Smith G; Price JC; Reynolds CF; Mathis CA; Greer P; Lopresti B; Mintun MA; Pollock BG; Ben-Eliezer D; Cantwell MN; Kaye W; DeKosky ST
Brain Res; 1998 Nov; 813(1):167-71. PubMed ID: 9824691
[TBL] [Abstract][Full Text] [Related]
31. Chronic effects of triiodothyronine in combination with imipramine on 5-HT transporter, 5-HT(1A) and 5-HT(2A) receptors in adult rat brain.
Moreau X; Jeanningros R; Mazzola-Pomietto P
Neuropsychopharmacology; 2001 Jun; 24(6):652-62. PubMed ID: 11331145
[TBL] [Abstract][Full Text] [Related]
32. A PET [18F]altanserin study of 5-HT2A receptor binding in the human brain and responses to painful heat stimulation.
Kupers R; Frokjaer VG; Naert A; Christensen R; Budtz-Joergensen E; Kehlet H; Knudsen GM
Neuroimage; 2009 Feb; 44(3):1001-7. PubMed ID: 19007894
[TBL] [Abstract][Full Text] [Related]
33. Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness.
Bailer UF; Price JC; Meltzer CC; Mathis CA; Frank GK; Weissfeld L; McConaha CW; Henry SE; Brooks-Achenbach S; Barbarich NC; Kaye WH
Neuropsychopharmacology; 2004 Jun; 29(6):1143-55. PubMed ID: 15054474
[TBL] [Abstract][Full Text] [Related]
34. Decreased hippocampal 5-HT(2A) receptor binding in older depressed patients using [18F]altanserin positron emission tomography.
Sheline YI; Mintun MA; Barch DM; Wilkins C; Snyder AZ; Moerlein SM
Neuropsychopharmacology; 2004 Dec; 29(12):2235-41. PubMed ID: 15367923
[TBL] [Abstract][Full Text] [Related]
35. [¹⁸F]Altanserin and small animal PET: impact of multidrug efflux transporters on ligand brain uptake and subsequent quantification of 5-HT₂A receptor densities in the rat brain.
Kroll T; Elmenhorst D; Matusch A; Celik AA; Wedekind F; Weisshaupt A; Beer S; Bauer A
Nucl Med Biol; 2014 Jan; 41(1):1-9. PubMed ID: 24120220
[TBL] [Abstract][Full Text] [Related]
36. Baseline prolactin and L-tryptophan availability predict response to antidepressant treatment in major depression.
Porter RJ; Mulder RT; Joyce PR
Psychopharmacology (Berl); 2003 Jan; 165(3):216-21. PubMed ID: 12439628
[TBL] [Abstract][Full Text] [Related]
37. Widespread increases of cortical serotonin type 2A receptor availability after hormone therapy in euthymic postmenopausal women.
Moses-Kolko EL; Berga SL; Greer PJ; Smith G; Cidis Meltzer C; Drevets WC
Fertil Steril; 2003 Sep; 80(3):554-9. PubMed ID: 12969697
[TBL] [Abstract][Full Text] [Related]
38. Suitability of [18F]altanserin and PET to determine 5-HT2A receptor availability in the rat brain: in vivo and in vitro validation of invasive and non-invasive kinetic models.
Kroll T; Elmenhorst D; Matusch A; Wedekind F; Weisshaupt A; Beer S; Bauer A
Mol Imaging Biol; 2013 Aug; 15(4):456-67. PubMed ID: 23456885
[TBL] [Abstract][Full Text] [Related]
39. Common HTR2A variants and 5-HTTLPR are not associated with human in vivo serotonin 2A receptor levels.
Spies M; Nasser A; Ozenne B; Jensen PS; Knudsen GM; Fisher PM
Hum Brain Mapp; 2020 Nov; 41(16):4518-4528. PubMed ID: 32697408
[TBL] [Abstract][Full Text] [Related]
40. 5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study.
Messa C; Colombo C; Moresco RM; Gobbo C; Galli L; Lucignani G; Gilardi MC; Rizzo G; Smeraldi E; Zanardi R; Artigas F; Fazio F
Psychopharmacology (Berl); 2003 Apr; 167(1):72-8. PubMed ID: 12632246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
